by Mark Lodge | Feb 3, 2022 | Uncategorised
This month the World marks its progress towards global cancer control on two dates:4 February is World Cancer Day and 15 February is International Childhood Cancer Day. These occasions are wonderful opportunities for advocacy, information sharing and celebrating collaborative efforts to address the catastrophic impact of cancer on patients and their families. The UICC is to be strongly commended on this year’s launch of the World Cancer Day three year Closing the Care Gap campaign building fairer, more equitable access to cancer care for all. Inequity in all its forms is a huge contributing factor to cancer mortality. But with cancer now being a leading cause of death worldwide, – killing one person every five seconds in the global populations of low and middle income countries – every month demands a reputable global platform highlighting new clinical, social and financial initiatives that address the issues surrounding malignant disease.
Last November (14-19 November 2021) London Global Cancer Week provided a free platform for 38 webinars and meetings hosted by The Commonwealth, WHO, IAEA, IARC, UICC, AORTIC, SLACOM and LACOG, NCI Center for Global Health and many other prominent institutions. Supported by sponsorship from Roche, Cancer Research UK and The Lancet Oncology, the Week drew an audience of over 2,500 people from 139 countries, enabling these attendees to engage with and enjoy the company of experts not only in the different branches of oncology and palliative care but also in politics, and finance.
At present there are several key cancer meetings like LGCW held annually across the world, but there is little sense of their themes being effortlessly carried over from one meeting to another in a continuum, or of the outcomes of the meetings providing direct benefit to populations. The great challenge for the Global Oncology community is to become a community; a community that helps mobilise high quality evidence, information and experience and that is inclusive, diverse, visionary and non-hierarchical. In this it can learn much from the success and vitality of proven initiatives such as Healthcare Information for All (HIFA). [https://hifa.org]
4 February World Cancer Day and 15 February International Childhood Cancer Day should be marked, celebrated and enjoyed, but they must also inspire us to raise our game during the 363 other days of the year, and strengthen our resolve to work together in common cause against a remorseless and deadly range of diseases.
Mark Lodge, Convenor London Global Cancer Week
by Mark Lodge | Nov 17, 2020 | Uncategorised
Monday 16th November, the second day of London Global Cancer Week and the first full day of meetings, has set the stage for the week to come. For the time being, and for many people in the world,. the phrase ‘The Big C’ no longer refers to cancer but to the Coronavirus or ‘COVID-19’. Following a filmed welcome by Dame Cally Palmer CBE, National Cancer Director NHS England, at 8 a.m. the first session – The COVID-19 pandemic: An African perspective – got straight to the heart of the matter.
Chaired by : Professor Frank Chinegwundoh, Consultant Urological Surgeon, Barts Health NHS Trust and AORTIC Vice-President Europe , and hosted by the African Organisation for Research and Training in Cancer (AORTIC), the three speakers Dr Abubakar Mohammed Bello, Head and Chief Consultant, Clinical and Radiation Oncologist, National Hospital, Abuja, Nigeria, Dr Yehoda M. Martei, MD – Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania and Dr Kwanele Asante, Chairperson, Ministerial Advisory Committee on Cancer Prevention and Control, Republic of South Africa described in detail how the impact of this year’s pandemic has cost the lives of cancer patients though delay and reduction of access to care. “The right to life of cancer patients have been undermined by COVID-19” Dr Asante explained, adding “the fact that we are even having this conversation is important. “
This hour long session was followed by two sessions hosted by the World Health Organisation that demonstrated to good effect the value of nations coming together in common purpose. Leading speakers from IARC, IAEA and WHO lined up to show a united front in the fight against cancer. “Today is about partnership . We will have to continue together” Dr Bente Mikkelsen, WHO Director for NCDS told the audience, although there were few illusions that the current situation is propitious. Lack of meaningful funding globally for cancer has been a long standing obstacle “We cannot wait longer to invest in cancer “ Dr Minghui Ren (WHO Assistant Director General NCDs) insisted; a view echoed by Dr Mikkelsen “We have seen huge underinvestment in NCDs , including cancer”. As a result 25 out of 53 African countries still do not have radiotherapy machines Eduardo Zubizarreta (IAEA) reported and only 35% of African patients needing radiotherapy receive the treatment. And, as Geraldine Arios de Goebl (IAEA) observed, “Cancer doesn’t stop for Covid”
In the second WHO session (“WHO Global Initiatives in Cancer: platforms for accelerated action ) the focus turned to WHO’s recently announced strategies on childhood cancers and cervical cancer. In her thoughtful presentation Princess Nono Simelala reminded the attendees that with cervical cancer there are pockets of underserved populations even in high income countries and she urged that all countries should move to HPV testing to prevent cervical cancers. For the first time ever, the world has committed to eliminate a cancer and, with the Launch of the Global Strategy to Accelerate the Elimination of Cervical Cancer due to take place the following day (Tuesday 17 November) there was no danger of the meeting not recognising the historic significance of that decision. “ The elimination of cervical cancer,” declared Cherian Varghese WHO Coordinator, Management of NCDs “ is the pathfinder to all cancer control “
The afternoon session, for the first time in five years not being held in the hallowed halls of the Royal Society of Medicine, got back on track. Titled The impact of COVID-19 on cancer management in low and middle income countries, it arranged its big guns to face the pandemic’s incursion for the benefit of its paying audience Its stellar roster of speakers included Ms Isabel Mestres, (City Cancer Challenge), Dr Hannah Tharmalingam, Vice-President, Clinical Oncol(Royal College of Radiologists, London) Dr Partha Basu, (Head, Screening Group IARC) , Dr Ophira Ginsburg, New York University, USA) Professor Karen Canfell (Cancer Council, New South Wales) Professor Mary Gospodarowicz, (Toronto, Canada), and Dr Manjit Dosanjh, (Honorary CERN Staff, European Organization for Nuclear Research (CERN)), with Professor Bente Mikkelsen (WHO) and Dr May Abdel-Wahab, (IAEA) gamely staying online after the morning’s session.
Keeping an eye on the continued underinvestment for cancer by governments despite the SDG goals Professor. Richard Sullivan wondered whether pandemic preparedness would crowd out cancer? Pointing out that the Incidence of COVID-19 is higher in cancer patients compared to general population Professor Warren Phipps (Ugandan Cancer Institute) described the sterling efforts that had been made to protect UCI staff through a WhatsApp-based screening tool developed in collaboration with the Fred Hutchinson Institute. Based at National Center for Radiotherapy and Nuclear Medicine, Korle-Bu Teaching Hospital, Accra, Ghana Dr Verna Vanderpuye’s presentation was reported by one listener to be ‘wonderful, emotional and an inspiration to listen to.’
Tuesday’s events promise to be equally fulfilling. The day begins early (at 8 a.m.) in India with the CReDO workshop Shaping the future of global oncology research. At 9.30 a.m. 9.30 am there will be a major event celebrating the Year of the Nurse -The Global Power of Oncology Nursing – hosted by the UK Oncology Nursing Society and the Royal College of Nuirsing. The day’s events will close with the meeting Research and Treatment of Paediatric Cancers During Covid-19: Global Perspectives hosted by INCTR and GCPA-Europe/SIDCER. All Tuesday’s meetings offer free registration.
by Mark Lodge | Nov 16, 2020 | Uncategorised
The UK Global Cancer Network was launched yesterday afternoon at an online meeting co-chaired by Professor Richard Cowan ( Consultant in Clinical Oncology and Director of The Christie School of Oncology , The Christie NHS Foundation Trust Manchester) and Dr Susannah Stanway(Consultant Medical Oncology, Breast Unit, Royal Marsden NHS Foundation Trust, Surrey). The meeting – the first event of London Global Cancer Week 2020 – began with a filmed welcome by Dame Cally Palmer CBE, NHS National Cancer Director for NHS England.
Attendees from across the UK heard presentations by Professor Richard Sullivan (Kings College London), Dr Satish Gopal (NCI Center for Global Health, USA) and Professor Bhawna Sirohi (Apollo Proton Centre, Chennai India). The mission of the Network is to enhance the UK’s contribution to cancer care in LMICs by bringing together the talent, resources and enthusiasm of individuals and organisations within the UK in a more strategic and collaborative body, with the intention of improving the outcome and experience of people affected by cancer in low and middle income countries. The Network’s first project will be to conduct a comprehensive and systematic mapping exercise of the existing and planned links and partnerships involving UK colleagues and colleagues in low and middle income countries in the field of cancer care.
The London Global Cancer Week programme for Monday 16 November will include events hosted by the African Organisation for Research and Training in Cancer (AORTIC), the World Health Organisation and the Royal Society of Medicine Oncology Group. Details about how to attend these meetings are available at www.lgcw.org.uk
by Simon_M | Nov 15, 2020 | Uncategorised
In November 2015 the Royal Society of Medicine’s Oncology Section hosted a meeting. Its focus was the state of cancer control in low and middle income countries; the regions of the world that see over half of the new cancer cases of cancer and nearly 70% of cancer deaths. This meeting was so successful that it subsequently ran annually”. At 3pm (GMT) on Sunday 15 November , despite being separated by the impact of the Coronavirus pandemic 40 researchers and clinicians will join together to launch a UK Global Cancer network.
“We are really excited about uniting those UK colleagues interested in cancer control in low- and middle- income countries and fragile countries together to work collaboratively ” Dr Susannah Stanway
Co chaired by Professor Richard Cowan ( Consultant in Clinical Oncology and Director of The Christie School of Oncology , The Christie NHS Foundation Trust Manchester) and Dr Susannah Stanway(Consultant Medical Oncology, Breast Unit, Royal Marsden NHS Foundation Trust, Surrey), the mission of the Network will be to enhance the UK’s contribution to cancer care in LMICs by bringing together the talent, resources and enthusiasm of individuals and organisations within the UK in a more strategic and collaborative body, with the intention of improving the outcome and experience of people affected by cancer in low and middle income countries.
“The UK GCN is something we have been waiting too long to appear. We now have an opportunity to draw on the wealth of experience, expertise and enthusiasm of colleagues across the UK to enhance our impact on the ever increasing burden of cancer in LMICs” – Professor Richard Cowan
This meeting will be first event in London Global Cancer Week 2020 (www.lgcw.org.uk) Speakers at the meeting will include Professor Richard Sullivan (Kings College London), Dr Satish Gopal (NCI Center for Global Health, USA),. Professor Bhawna Sirohi (Apollo Proton Centre, Chennai India) and Mark Lodge (International Network for Cancer Treatment and Research UK). It is likely that the Network’s first project will be the mapping of the links between the UK and the low and middle income countries in the area of cancer control
by Mark Lodge | Aug 19, 2020 | Uncategorised
COVID-19 : The Perfect Storm
The human response to the Coronavirus emergency is revealing the shortcomings of every health system. In Kenya, a country with 47887 new cases of cancer per year and a 5 year prevalence of 86592 cases (GLOBOCAN 2018), cancer patients are facing a Perfect Storm due to the COVID-19 pandemic. Lockdown has limited access to cancer facilities and many doctors and nurses who would have been treating cancer patients have been deployed to deal with the Coronavirus emergency. At the same time, fearing contagion cancer patients are reluctant to go to hospital for diagnostic tests and for treatment, and social distancing measures are limiting how many patients are allowed to attend hospitals.
In a recent VOA posting Catherine Wachira, Chair of the Kenya Network of Cancer Organisations (KENCO) describes how distance also impacts on access to life saving health care:
“A large number of the oncologists we have in Kenya today are based in Nairobi. What this means is that patients from all over Kenya will have to come all the way to Nairobi to see these oncologists. With the lockdown measures in place due to the COVID-19 crisis it becomes a challenge.”
In her interview Catherine points out that the economic damage caused by the lockdown and social distancing has also affected patients:
The loss of income means that they are not only not able to buy their drugs but also to get proper nutrition. When a patient is undergoing chemotherapy or radiotherapy it is quite crucial and quite vital that their nutritional needs are well met.
See her interview and hear first hand how COVID-19 restrictions are affecting the care of cancer patients in Kenya at https://www.voazimbabwe.com/a/kenya-cancer-covid-resrictions/5530645.html. @kenconetwork #londonglobalcancer @lgcw2020